Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling

Acta Orthopaedica

Volumn 77, Issue 1, 2006, Pages 23-26

  Tägil, Magnus ^a   Aspenberg, Per ^b   Åstrand, Jörgen ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BONE GRAFT; BONE MARROW; BONE NECROSIS; BONE REMODELING; CARTILAGE; CONTROLLED STUDY; MALE; MATERIAL COATING; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; RAT; ANIMAL; BONE DENSITY; BONE TRANSPLANTATION; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GRAFT REJECTION; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONE RESORPTION; BONE TRANSPLANTATION; DIPHOSPHONATES; FEMALE; GRAFT REJECTION; IMIDAZOLES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33645059728     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670610045650     Document Type: Article

References (11)

1. Aspenberg P, Wang J S. A new bone chamber used for measuring osteoconduction in rats. Eur J Exp Musculoskel Res 1993; 2: 69-74.
2. Aspenberg P, Åstrand J. Bone allografts pretreated with a bisphosphonate are not resorbed. Acta Orthop Scand 2002; 73: 20-3.
3. Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000; 71: 553-7.
4. Lai K A, Shen W J, Yang C Y, Shao C J, Hsu J T, Lin R M. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg (Am) 2005; 87: 2155-9.
5. Little D G, Peat R A, Mcevoy A, Williams P R, Smith E J, Baldock P A. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 2003a; 18: 2016-22.
6. Little D G, Smith N C, Williams P R, Briody J N, Bilston L E, Smith E J, Gardiner E M, Cowell C T. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 2003b; 18: 1300-7.
7. Reid I R, Brown J P, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer J P, Kaufman J M, Jaeger P, Body J J, Brandi M L, Broell J, Di Micco R, Genazzani A R, Felsenberg D, Happ J, Hooper M J, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier P J. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002; 28: 653-61.
8. Rogers M J. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 2003; 9: 2643-58.
9. Rogers M J, Gordon S, Benford H L, Coxon F P, Luckman S P, Monkkonen J, Frith J C. Cellular and molecular mechanisms of action of bisphosphonates. Cancer (Suppl 12) 2000; 15: 882961-78.
10. Åstrand J, Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization.A bone chamber study in rats. BMC Musculoskelet Disord 2002; 3: 19.
11. Williams R M, Kiefhaber T R, Sommerkamp T G, Stern P J. Treatment of unstable dorsal proximal interphalangeal fracture/dislocations using a hemi-hamate autograft. J Hand Surg (Am) 2003; 28: 856-65.